|








*British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC;
Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC;
Department of Medicine, University of British Columbia, Vancouver, BC;
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC
Correspondence to: Dr. Martin T. Schechter, Department of Health Care and Epidemiology, University of British Columbia, 5804 Fairview Ave., Vancouver BC V6T 1Z3; fax 604 806-9044; martin.schechter{at}ubc.ca
| Abstract |
|---|
|
|
|---|
Methods: The Vancouver Injection Drug User Study is a prospective cohort study of injection drug users that began in 1996. The present study relied primarily on data acquired from participants who were seen during the 30-day periods immediately before and after the seizure. We compared drug use and behavioural characteristics, heroin and cocaine prices, and participants' reports of whether law enforcement had affected their source of drugs or the types of drugs available on the street, as well as overdoses, in these 2 periods.
Results: The 138 participants seen before the seizure were similar to the 123 participants seen after the seizure with respect to age, sex, ethnic background, education, HIV serostatus, neighbourhood residence, instability of housing, employment status, use of methadone maintenance therapy and all other measured potential confounders (all p > 0.10). We found no difference in the extent to which participants in the 2 groups reported daily use of heroin, frequency of nonfatal overdoses, or whether law enforcement had affected their source of drugs or the types of drugs available on the street (all p > 0.10). Although we detected no difference in the price of cocaine, the median reported price of heroin went down after the seizure (p = 0.034), which suggests that other shipments compensated for the seizure. External evaluations of deaths from overdoses and heroin purity indicated that the seizure had no impact, nor was any impact seen when the periods of analysis were extended.
Interpretation: The massive heroin seizure appeared to have no measurable public health benefit. Closer scrutiny of enforcement efforts is warranted to ensure that resources are delivered to the most efficient and cost-effective public health programs.
Few studies have attempted to evaluate the impact of the supply-reduction strategy on community drug-use patterns. An Australian study found no evidence that heroin seizures affected the price, purity or perceived availability of heroin. Similarly, despite spending of over US$18 billion annually on supply-reduction efforts in the United States, the most recent heroin availability report from the US Office of National Drug Control Policy stated that the price of heroin in that country decreased 3-fold between 1988 and 2000, while purity has reached an all-time high.
On Sept. 2, 2000, Canadian law enforcement officials seized approximately 100 kg of uncut heroin soon after its arrival in the port of Vancouver, in what was reportedly the nation's largest-ever seizure of the drug. To put this seizure in perspective, the US Drug Enforcement Administration's 10-month Operation White Horse resulted in the seizure of 6.5 kg of heroin, and the total amount of heroin seized by the US Customs Service along that country's southwest border during the entire year 2000 was 113 kg.
In the wake of the Vancouver seizure, it was suggested that the removal of this quantity of heroin from the market could substantially limit the supply of the drug and could keep prices beyond the range of youth at high risk for experimentation, and that it was responsible for a decline in the city's overdose rate. We sought to determine if the seizure had a measurable effect on the price of drugs, injection drug using behaviour, the incidence of overdoses or the supply of heroin to Vancouver's IDUs.
| Methods |
|---|
|
|
|---|
At baseline and semiannually thereafter, subjects provided blood samples and completed an interviewer-administered questionnaire. The questionnaire elicited demographic data including age, sex and place of residence, as well as drug use, risk behaviour and attendance at drug treatment. In addition, since the cohort's inception several general questions have been added to evaluate the effect of law enforcement efforts on the supply of drugs and patterns of drug use. Participants were also asked to report the current street price per "point" (single shot) of injection heroin and injection cocaine.
For the primary analysis in this study we assumed a priori that acute street-level impacts would be measurable within a month starting the day after the seizure., Therefore, pre-seizure and post-seizure participants were defined as those seen for follow-up within 30 days before and 30 days after Sept. 2, 2000, respectively. In addition, because of uncertainty concerning the appropriateness of the 30-day period for observing any impact of the seizure, we conducted several sensitivity analyses. First, we compared participants seen during the 60 days before Sept. 2, 2000, with those seen during the 60 days after this date. Second, we evaluated participants seen in 6 successive 2-week periods after Sept. 2, 2000.
Statistical analyses were applied to compare pre- and post-seizure participants. Categorical explanatory variables were analyzed with Pearson's
2 test and Fisher's exact test, and continuous variables were analyzed with the Wilcoxon rank-sum test. In addition, to adjust for potential confounding due to differences between the IDUs seen before and after the seizure, we conducted a logistic regression analysis in which the dependent variable was the period (before v. after).
| Results |
|---|
|
|
|---|
In univariate analyses of drug use and behavioural characteristics (
), we found no difference in the proportion of participants who reported that law enforcement had affected their source of drugs (p = 0.55) or the type of drugs available on the street (p = 0.73). Similarly, we found no differences in overall drug-use pattern (p = 0.60), injection drug-use pattern (p = 0.13), current heroin use (p = 0.57), frequency of heroin injection (p = 0.52) or frequency of cocaine injection (p = 0.42). In addition, we did not detect any difference in the proportion of participants reporting a recent nonfatal overdose (within the previous 6 months) (p = 0.12). Although the seizure was not associated with a change in the per-point price of cocaine (p = 0.36), we did detect a statistically significant decrease in the per-point price of heroin, from a median of $20 before the seizure to a median of $16 after the seizure (p = 0.034). After adjustment for all combinations of potential confounders, the decrease in the price of heroin remained independently associated with the post-seizure period in logistic regression analyses (p < 0.05)
|
Furthermore, our findings were unaffected when we doubled the length of the pre- and post-seizure periods and compared the 317 participants seen during the 60 days before Sept. 2, 2000, with the 259 participants seen during the 60 days after this date. In this analysis, the median post-seizure per-point price of heroin was higher than for the 30-day period, at $18 (interquartile range $14 to $20), but it was still lower than the 60-day pre-seizure price, which remained unchanged at $20 (interquartile range $15 to $20).
The percentages of participants reporting current heroin use, methadone maintenance therapy and recent nonfatal overdose during the period from 28 days (4 weeks) before Sept. 2, 2000, to 12 weeks after this date are shown in
. For all 3 variables, comparisons of periods were nonsignificant except for the comparisons of period 2 and period 1 (the two 2-week periods before the seizure) with period 2 (the second 2-week period after the seizure) for nonfatal overdoses (p = 0.08 and p = 0.001 respectively); this variable was moderately greater during period 2 than during periods 2 and 1. Not shown in the figure is the percentage of participants who reported that law enforcement had affected the types of drugs available on the street. On average, 22.2% of participants reported that law enforcement had affected the types of drugs available during the 4 weeks before the seizure, whereas 19.5% of participants reported that law enforcement had affected the types of drugs available during the 12 weeks after the seizure (p = 0.19).
|
| Interpretation |
|---|
|
|
|---|
Several factors may explain our observations. First, we must accept the possibility that the results can be explained by chance or confounding factors. Although we detected no evidence of a significant difference between the 2 study groups, it is possible that unmeasured confounding persisted. In addition, we recognize that the reduction in the price of heroin that we observed was probably due to random fluctuation or compensatory shipments and was not causally connected to the seizure. With regard to the possibility that compensatory shipments explain our findings, previous studies have found that heroin seizures tend to correlate with times of high production and supply of drugs., We do not believe that interview bias played a role because the interviews were not conducted to assess the effect of the seizure but rather constituted the data instrument for an ongoing HIV incidence study; thus the interviewers and participants were in effect "blind" to this eventual use of the data. We should also note that although 148 (56.7%) of those considered in the present analyses were active heroin injectors, only 75 (28.7%) injected heroin daily. Nevertheless, the results were unaffected when we restricted the analysis to current heroin users (data not shown).
It could be argued that a 30-day period after the seizure was insufficient to capture a reduction in supply due to the seizure. To address this possibility, we conducted additional analyses and detected no difference when we examined data for a full 12 weeks after the seizure. It could also be argued that the heroin shipment was never intended for the local market. Although the inability to determine with certainty the final destination of the heroin is a limitation of the present study, the circumstances of the seizure suggest that the heroin was destined for the Vancouver market. Specifically, the seizure was the result of a 20-month investigation by the Vancouver Royal Canadian Mounted Police Asian Organized Crime Unit, which led to the arrest of several Vancouver men. During the investigation, information was acquired that led officials to conclude that the heroin was destined for the local market.,, Nevertheless, had the heroin been destined for shipment away from the market created by the area's estimated 5000 to 10 000 injection drug users, this would suggest that the local market was already saturated., Finally, it could be argued that the seizure led suppliers to reduce the purity of the heroin they sold so as to maintain the quantity of drug available. However, participants reported no difference in their source of drugs or the type of drugs available, and we found no decreases in overdoses or heroin use, nor any change in methadone use when the 12-week post-seizure period was examined (
). All of these variables have previously been associated with fluctuations in the purity of street-level heroin.,,
Externally compiled data appear to support our findings. Specifically, there were 10 fatal overdose deaths in the month before the seizure, whereas there was an average of 13.3 overdose deaths per month during the 3 months after the seizure (monthly illicit drug overdose statistics for 2000; BC Coroner Service, unpublished data). In addition, data from Health Canada's Drug Analysis Services, a group that often tests the purity of heroin samples provided by police, showed no decrease in the purity of heroin samples tested during the 3-month periods before and after the seizure (Health Canada, Drug Analysis Services, Burnaby, BC, unpublished data).
Analyses conducted by the United Nations Office for Drug Control and Crime Prevention suggest that a maximum of 5% of the global illegal drug flow is seized by law enforcement agencies. For this reason, despite the expenditure of tens of billions of dollars annually on drug interdiction efforts in North America, heroin purity has increased and prices have markedly decreased since the late 1980s., In turn, high HIV incidence rates have persisted, and overdose is among the leading cause of death in many large Canadian and US cities.,,, In Baltimore, for example, overdose deaths increased by more than 425% between 1990 and 1997.
In the present study we observed no beneficial public health effects of Canada's largest-ever heroin seizure. In our view, the most plausible explanation is that the seizure had no significant effect on the supply of heroin in this locality. This conclusion is supported by a recent report by the World Customs Organization, which found that even post-September 11 security measures have had a "negligible" impact on the influx of illicit drugs into the US. Given the size of the seizure relative to other large heroin seizures,, our findings raise serious questions about the potential for Canada's present drug policies to adequately control the drug use epidemic through supply-side interventions. It is critical to emphasize our view that fault does not lie with the front-line law enforcement officers who are involved in supply-side strategies at the operational level. Rather, the responsibility lies with the politicians and policy-makers who continue to direct the overwhelming majority of resources into failing supply-reduction strategies, despite the wealth of scientific evidence demonstrating their ineffectiveness.,,, Our findings support the strong consensus that curbing the HIV and overdose epidemics will require a shift in emphasis toward alternative strategies based on prevention, treatment and harm reduction, even if this shift necessitates a diversion of resources away from criminal justice interventions.,,,,,
| Footnotes |
|---|
Contributors: Evan Wood and Martin Schechter designed the study and prepared the first draft of the manuscript. All authors played central roles in the conception of the study and the interpretation of the data and contributed to various drafts of the manuscript.
Acknowledgements: Evan Wood is supported by the Canadian Institutes for Health Research and the BC Health Research Foundation. Martin Schechter holds a tier I Canada Research Chair in HIV/AIDS and Urban Population Health. The study was supported by the US National Institutes of Health (grant RO1 DA11591).
We thank Bonnie Devlin, Caitlin Johnston, Robin Brooks, Suzy Coulter, Steve Kain, Guillermo Fernandez, John Charette, Will Small, Peter Vann, Thomas Kerr and Nancy Laliberté for their research and administrative assistance, and all the participants in the VIDUS study.
Competing interests: None declared.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. Wood MD PhD and T. Kerr PhD Methamphetamine strategy requires evaluation Can. Med. Assoc. J., September 23, 2008; 179(7): 677 - 677. [Full Text] [PDF] |
||||
![]() |
E. Wood, J. S.G. Montaner, K. Li, R. Zhang, L. Barney, S. A. Strathdee, M. W. Tyndall, and T. Kerr Burden of HIV Infection Among Aboriginal Injection Drug Users in Vancouver, British Columbia Am J Public Health, March 1, 2008; 98(3): 515 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mazerolle, D. Soole, and S. Rombouts Drug Law Enforcement: A Review of the Evaluation Literature Police Quarterly, June 1, 2007; 10(2): 115 - 153. [Abstract] [PDF] |
||||
![]() |
B. Fischer, J. Rehm, J. Patra, and M. Firestone Cruz Changes in illicit opioid use across Canada. Can. Med. Assoc. J., November 21, 2006; 175(11): 1385 - 1385. [Full Text] [PDF] |
||||
![]() |
E. Wood, P. M. Spittal, W. Small, T. Kerr, K. Li, R. S. Hogg, M. W. Tyndall, J. S.G. Montaner, and M. T. Schechter Displacement of Canada's largest public illicit drug market in response to a police crackdown Can. Med. Assoc. J., May 11, 2004; 170(10): 1551 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
Minerva BMJ, October 6, 2003; 327(7418): E218 - 218. [Full Text] [PDF] |
||||
![]() |
M. Copeman Drug supply and drug abuse Can. Med. Assoc. J., April 29, 2003; 168(9): 1113 - 1113. [Full Text] [PDF] |
||||
![]() |
E. Wood, M. W. Tyndall, and M. T. Schechter Drug supply and drug abuse Can. Med. Assoc. J., April 29, 2003; 168(9): 1113 - 1113. [Full Text] [PDF] |
||||
![]() |
Minerva BMJ, February 8, 2003; 326(7384): 344 - 344. [Full Text] [PDF] |
||||
Read all eLetters
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||